Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
Blood. 2010 Feb 18;115(7):1364-73. doi: 10.1182/blood-2009-10-246322. Epub 2009 Dec 10.
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), one of the most widely spread immune receptors, attenuates immune cell activation when bound to specific sites in collagen. The collagen-binding domain of LAIR-1 is homologous to that of glycoprotein VI (GPVI), a collagen receptor crucial for platelet activation. Because LAIR-1 and GPVI also display overlapping collagen-binding specificities, a common structural basis for collagen recognition would appear likely. Therefore, it is crucial to gain insight into the molecular interaction of both receptors with their ligand to prevent unwanted cross-reactions during therapeutic intervention. We determined the crystal structure of LAIR-1 and mapped its collagen-binding site by nuclear magnetic resonance (NMR) titrations and mutagenesis. Our data identify R59, E61, and W109 as key residues for collagen interaction. These residues are strictly conserved in LAIR-1 and GPVI alike; however, they are located outside the previously proposed GPVI collagen-binding site. Our data provide evidence for an unanticipated mechanism of collagen recognition common to LAIR-1 and GPVI. This fundamental insight will contribute to the exploration of specific means of intervention in collagen-induced signaling in immunity and hemostasis.
白细胞相关免疫球蛋白样受体-1(LAIR-1)是分布最广泛的免疫受体之一,当与胶原蛋白中的特定位点结合时,会减弱免疫细胞的激活。LAIR-1 的胶原蛋白结合域与糖蛋白 VI(GPVI)同源,GPVI 是血小板激活的关键胶原蛋白受体。由于 LAIR-1 和 GPVI 也显示出重叠的胶原蛋白结合特异性,因此似乎存在胶原蛋白识别的共同结构基础。因此,深入了解这两个受体与配体的分子相互作用对于防止治疗干预期间发生不必要的交叉反应至关重要。我们通过核磁共振(NMR)滴定和突变分析确定了 LAIR-1 的晶体结构,并绘制了其胶原蛋白结合位点。我们的数据确定 R59、E61 和 W109 是与胶原蛋白相互作用的关键残基。这些残基在 LAIR-1 和 GPVI 中严格保守;然而,它们位于先前提出的 GPVI 胶原蛋白结合位点之外。我们的数据为 LAIR-1 和 GPVI 共有的胶原识别提供了一个出乎意料的机制的证据。这一基本认识将有助于探索在免疫和止血中针对胶原蛋白诱导信号的特异性干预手段。